Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 1986-1991

  Colao, Annamaria ^a   Marzullo, Paolo ^a   Spiezia, Stefano ^b   Ferone, Diego ^a   Giaccio, Assunta ^a   Cerbone, Gaetana ^a   Pivonello, Rosario ^a   Somma, Carolina D I ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Emergency Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; MALE; ORGAN SIZE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0033305345     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.6.5776     Document Type: Article

References (30)

1. The endocrinology and developmental biology of the prostate
2. Occult prostate cancer in men with low serum testosterone levels
3. Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence
4. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors
5. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
6. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
7. Insulin-like growth factor-binding proteins in serum and other bilogiocal fluids: Regulation and function
8. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
9. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen
10. Insulin-like growth factor binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
11. Prostate-specific antigen (PSA) is an insulin-growth factor binding protein-3 protease found in seminal plasma
12. Prostate hyperplasia: An unknown feature of acromegaly
13. GH and PRL excess
14. The diagnosis of growth hormone deficiency in children and adults
15. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US
16. Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume
17. The development of human benign prostatic hyperplasia with age
18. Normal histology of the prostate
19. Peptide growth factors in the prostate as mediators of stromal epithelial interactions
20. Growth hormone directly affects the function of the different lobes of the rat prostate
21. Insulin-like growth factor (IGF) system components in human prostatic cancer cell lines: LNCaP, DU145 and PC-3 cells
22. Growth factor involvement in progression of prostate cancer
23. The prostatic IGF system: New levels of complexity
24. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: Relationship with binding proteins 2 and 3 and androgens
25. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor β1 on programmed cell death through a p53- and IGF-indipendent mechanism
26. Mortality and cancer incidence in acromegaly: A retrospective cohort study
27. Increased incidence of neoplasia in patients with pituitary adenomas
28. Insulin-like growth factor-I in relation to prostate cancer and benign prostatic hyperplasia
29. Circulating concentrations of Insulin-like growth factor-I and risk of breast cancer
30. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture